BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3280894)

  • 1. [Systolic intervals in dilated heart insufficiency. Influence of vasodilator treatment].
    González-Juanatey JR; Amaro Cendón A; Vega Fernández M; Gil de la Peña M
    Med Clin (Barc); 1988 Jan; 90(3):93-6. PubMed ID: 3280894
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent progress in the treatment of cardiac insufficiency. Contribution of vasodilator agents].
    Ivanciuc I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):385-92. PubMed ID: 44561
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilators in the treatment of congestive heart failure.
    Ciafone RA
    Conn Med; 1983 Oct; 47(10):614-8. PubMed ID: 6414758
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasodilator therapy of congestive heart failure.
    Cohn JN
    Adv Intern Med; 1980; 26():293-315. PubMed ID: 6784453
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peripheral vasodilator in cardiac insufficiency in the acute period of myocardial infarction].
    Ruksin VV
    Sov Med; 1985; (2):54-6. PubMed ID: 3992326
    [No Abstract]   [Full Text] [Related]  

  • 7. Systolic time intervals. Noninvasive assessment of vasodilator therapy for congestive failure.
    Whiting RB
    Chest; 1981 Feb; 79(2):222-3. PubMed ID: 7460653
    [No Abstract]   [Full Text] [Related]  

  • 8. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B
    G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
    Shevchenko VA
    Vrach Delo; 1983 Oct; (10):8-12. PubMed ID: 6139918
    [No Abstract]   [Full Text] [Related]  

  • 10. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
    Adigun AQ; Ajayi OE; Sofowora GG; Ajayi AA
    Int J Cardiol; 1998 Nov; 67(1):81-6. PubMed ID: 9880204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New aspects in the treatment of acute cardiac insufficiency].
    Sterz H
    Wien Med Wochenschr; 1978 May; 128(9):256-61. PubMed ID: 27016
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of peripheral vasodilators on arrhythmia in patients with chronic coronary insufficiency].
    Mareev VIu; Kazeĭ DV; Ageev FT; Shevliagin SA; Grigor'iants RA
    Kardiologiia; 1992 Apr; 32(4):30-5. PubMed ID: 1405230
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vasodilator agents in the treatment of heart failure].
    Prati PL; Manfrin M
    G Ital Cardiol; 1978; 8(1):1-11. PubMed ID: 415927
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of vasodilator drugs in congestive heart failure.
    Med Lett Drugs Ther; 1978 Oct; 20(20):89-91. PubMed ID: 703684
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasodilator therapy for chronic congestive heart failure.
    Abrams J
    JAMA; 1985 Dec; 254(21):3070-4. PubMed ID: 3932697
    [No Abstract]   [Full Text] [Related]  

  • 18. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
    Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of sublingual isosorbide dinitrate on systolic time intervals in normal subjects and those with coronary disease].
    Paterna S; Campisi D; Bivona A; Valenza M; Di Maso N; Alaimo V
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):29-35. PubMed ID: 6704251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.